Statement Of Cash Flows

TAKARA BIO INC. - Filing #7322771

Concept 2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
4,361,000,000 JPY
46,028,000,000 JPY
Interest and dividends received
166,000,000 JPY
116,000,000 JPY
Interest paid
-22,000,000 JPY
-24,000,000 JPY
Income taxes paid
-2,359,000,000 JPY
-9,902,000,000 JPY
Cash flows from operating activities
Net cash provided by (used in) operating activities
1,711,000,000 JPY
36,897,000,000 JPY
Cash flows from operating activities
Cash flows from investing activities
Net cash provided by (used in) investing activities
-13,043,000,000 JPY
-6,693,000,000 JPY
Other, net
-19,000,000 JPY
7,000,000 JPY
Cash flows from facilities maintenance and investing activities
Cash flows from financing activities
Dividends paid
-5,052,000,000 JPY
-3,968,000,000 JPY
Net cash provided by (used in) financing activities
-5,233,000,000 JPY
-4,119,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
678,000,000 JPY
813,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-15,886,000,000 JPY
26,897,000,000 JPY
Cash and cash equivalents
33,171,000,000 JPY
49,058,000,000 JPY
22,160,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.